Singapore markets open in 1 hour 19 minutes

AstraZeneca PLC (AZNCF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
159.12-0.24 (-0.15%)
At close: 12:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 241.96B
Enterprise value 268.49B
Trailing P/E 39.29
Forward P/E 18.80
PEG ratio (5-yr expected) 0.98
Price/sales (ttm)5.22
Price/book (mrq)6.59
Enterprise value/revenue 5.64
Enterprise value/EBITDA 19.51

Trading information

Stock price history

Beta (5Y monthly) 0.16
52-week change 312.74%
S&P500 52-week change 326.14%
52-week high 3159.36
52-week low 3118.16
50-day moving average 3142.73
200-day moving average 3134.22

Share statistics

Avg vol (3-month) 33.42k
Avg vol (10-day) 31.01k
Shares outstanding 51.55B
Implied shares outstanding 61.56B
Float 81.54B
% held by insiders 10.05%
% held by institutions 150.24%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.86
Forward annual dividend yield 41.80%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 31.82%
5-year average dividend yield 42.47
Payout ratio 471.30%
Dividend date 309 Sept 2019
Ex-dividend date 422 Feb 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.30%
Operating margin (ttm)26.11%

Management effectiveness

Return on assets (ttm)7.04%
Return on equity (ttm)17.29%

Income statement

Revenue (ttm)47.61B
Revenue per share (ttm)30.74
Quarterly revenue growth (yoy)16.50%
Gross profit (ttm)N/A
EBITDA 15.8B
Net income avi to common (ttm)6.33B
Diluted EPS (ttm)4.06
Quarterly earnings growth (yoy)20.90%

Balance sheet

Total cash (mrq)8.02B
Total cash per share (mrq)5.18
Total debt (mrq)34.69B
Total debt/equity (mrq)92.51%
Current ratio (mrq)0.89
Book value per share (mrq)24.17

Cash flow statement

Operating cash flow (ttm)9.7B
Levered free cash flow (ttm)8.68B